Treatment and Management of Dementia Due to Alzheimer’s Disease-Reference-Cited by-同舟云学术

Treatment and Management of Dementia Due to Alzheimer’s Disease

Published:2015-07-03 Issue:8 Volume:17 Page:
ISSN:1092-8480
Container-title:Current Treatment Options in Neurology
language:en
Short-container-title:Curr Treat Options Neurol

Author:

Molano Jennifer Rose V.,Bratt Robin,Shatz Rhonna

Publisher

Springer Science and Business Media LLC

Subject

Clinical Neurology

Link

http://link.springer.com/content/pdf/10.1007/s11940-015-0363-4.pdf

Reference78 articles.

1. McKhann GM et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging and the Alzheimer’s Association workgroup. Alzheimer’s Dement. 2011;7(3):263–9.

2. Odenheimer G et al. Quality improvement in neurology: dementia management quality measures. Neurology. 2013;81:1545–9. Brief overview of the dementia management quality measures with a link to the Physician Consortium for Performance Improvement Website.

3. Barnard ND et al. Dietary and lifestyle guidelines for the prevention of Alzheimer’s disease. Neurobiol Aging. 2014;35:S74–8.

4. Ngandu T et al. A 2 year multi-domain intervention of diet, exercise, cognitive training and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER); a randomized controlled trial. Lancet. 2015. doi: 10.1016/S0140-6736(15)60461-5 . Large, randomized controlled trial showing the importance of lifestyle modification in modifying cognitive decline.

5. Singh B et al. Association of Mediterranean diet with mild cognitive impairment and Alzheimer’s disease: a systematic review and meta-analysis. J Alzheimers Dis. 2014;39(2):271–82.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prescribing medications of questionable benefit prior to death: a retrospective study on older nursing home residents with and without dementia in Germany;European Journal of Clinical Pharmacology;2020-03-26

2. Combining Chalcones with Donepezil to Inhibit Both Cholinesterases and Aβ Fibril Assembly;Molecules;2019-12-24

3. Design, synthesis and biological evaluation of novel coumarin- N -benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease;European Journal of Medicinal Chemistry;2017-10

4. Design, synthesis and biological evaluation of novel donepezil–coumarin hybrids as multi-target agents for the treatment of Alzheimer’s disease;Bioorganic & Medicinal Chemistry;2016-04